Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacek Bil

Showing results (101-110 of 124) with videos related to

Pageof 13
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 11, 2024
Intentional coronary revascularization versus conservative therapy in patients after peripheral artery revascularization due to critical limb ischemia: the INCORPORATE trialGabor G Toth, Marianne Brodmann, Sadeek S Kanoun Schnur, et al.
The American Journal of Pathology|June 4, 2010
Cardiotoxicity of the anticancer therapeutic agent bortezomibDominika Nowis, Michał Maczewski, Urszula Mackiewicz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 6, 2025
Biodistribution, Safety Profile, and Radiation Dosimetry of [<sup>18</sup>F]SYN2, a PET Cardiac Perfusion Tracer, in Healthy SubjectsJuhani Knuuti, Małgorzata Kobylecka, Seweryn Krajewski, et al.
Neoplasia (New York, N.Y.)|May 12, 2012
Statins impair glucose uptake in tumor cellsAgata Malenda, Anna Skrobanska, Tadeusz Issat, et al.
Cancer Research|May 14, 2009
Proteasome inhibition potentiates antitumor effects of photodynamic therapy in mice through induction of endoplasmic reticulum stress and unfolded protein responseAngelika Szokalska, Marcin Makowski, Dominika Nowis, et al.
Journal of Clinical Medicine|August 10, 2024
Drug-Eluting Balloons and Drug-Eluting Stents in Diabetic Patients Undergoing Percutaneous Coronary Intervention Due to Restenosis-DM-Dragon RegistryPiotr Niezgoda, Michał Kasprzak, Jacek Kubica, et al.
Journal of Clinical Medicine|April 3, 2021
Characteristics and Treatment of Atrial Fibrillation with Respect to the Presence or Absence of Heart Failure. Insights from the Multicenter Polish Atrial Fibrillation (POL-AF) RegistryMonika Gawałko, Monika Budnik, Iwona Gorczyca, et al.
International Journal of Environmental Research and Public Health|October 14, 2022
Do Patients with Atrial Fibrillation and a History of Ischemic Stroke Overuse Reduced Doses of NOACs?-Results of the Polish Atrial Fibrillation (POL-AF) RegistryAnna Szyszkowska, Łukasz Kuźma, Beata Wożakowska-Kapłon, et al.
Journal of Clinical Medicine|November 10, 2020
Trends in the Prescription of Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation: Results of the Polish Atrial Fibrillation (POL-AF) RegistryIwona Gorczyca, Olga Jelonek, Beata Uziębło-Życzkowska, et al.
Cardiovascular Diagnosis and Therapy|March 12, 2021
Antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention, including compliance with current guidelines-data from the POLish Atrial Fibrillation (POL-AF) RegistryBeata Uziębło-Życzkowska, Paweł Krzesiński, Małgorzata Maciorowska, et al.
Pageof 13

Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 11, 2024
Intentional coronary revascularization versus conservative therapy in patients after peripheral artery revascularization due to critical limb ischemia: the INCORPORATE trialGabor G Toth, Marianne Brodmann, Sadeek S Kanoun Schnur, et al.
The American Journal of Pathology|June 4, 2010
Cardiotoxicity of the anticancer therapeutic agent bortezomibDominika Nowis, Michał Maczewski, Urszula Mackiewicz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 6, 2025
Biodistribution, Safety Profile, and Radiation Dosimetry of [<sup>18</sup>F]SYN2, a PET Cardiac Perfusion Tracer, in Healthy SubjectsJuhani Knuuti, Małgorzata Kobylecka, Seweryn Krajewski, et al.
Neoplasia (New York, N.Y.)|May 12, 2012
Statins impair glucose uptake in tumor cellsAgata Malenda, Anna Skrobanska, Tadeusz Issat, et al.
Cancer Research|May 14, 2009
Proteasome inhibition potentiates antitumor effects of photodynamic therapy in mice through induction of endoplasmic reticulum stress and unfolded protein responseAngelika Szokalska, Marcin Makowski, Dominika Nowis, et al.
Journal of Clinical Medicine|August 10, 2024
Drug-Eluting Balloons and Drug-Eluting Stents in Diabetic Patients Undergoing Percutaneous Coronary Intervention Due to Restenosis-DM-Dragon RegistryPiotr Niezgoda, Michał Kasprzak, Jacek Kubica, et al.
Journal of Clinical Medicine|April 3, 2021
Characteristics and Treatment of Atrial Fibrillation with Respect to the Presence or Absence of Heart Failure. Insights from the Multicenter Polish Atrial Fibrillation (POL-AF) RegistryMonika Gawałko, Monika Budnik, Iwona Gorczyca, et al.
International Journal of Environmental Research and Public Health|October 14, 2022
Do Patients with Atrial Fibrillation and a History of Ischemic Stroke Overuse Reduced Doses of NOACs?-Results of the Polish Atrial Fibrillation (POL-AF) RegistryAnna Szyszkowska, Łukasz Kuźma, Beata Wożakowska-Kapłon, et al.
Journal of Clinical Medicine|November 10, 2020
Trends in the Prescription of Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation: Results of the Polish Atrial Fibrillation (POL-AF) RegistryIwona Gorczyca, Olga Jelonek, Beata Uziębło-Życzkowska, et al.
Cardiovascular Diagnosis and Therapy|March 12, 2021
Antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention, including compliance with current guidelines-data from the POLish Atrial Fibrillation (POL-AF) RegistryBeata Uziębło-Życzkowska, Paweł Krzesiński, Małgorzata Maciorowska, et al.
Pageof 13